Fundz

Bio Atla,Llc reported raising $39 Million in an initial SEC Form D filing, from an offering of $39 Million

PUBLIC · BCABJul 21, 2015

Amount Raised

$39 Million

$39 Million sold, per SEC Form D (first sale Jul 21, 2015)

Round Type

Venture

San DiegoBiotechnologyHealth CareTherapeuticsBiopharma

Quick answer

BioAtla raised $39 Million in a funding round, dated July 21, 2015. BioAtla is based in San Diego, California, United States.

How much did BioAtla raise?
BioAtla raised $39 Million in a funding round on July 21, 2015.
What does BioAtla do?
BioAtla, Inc. is a biotechnology company focused on the development of innovative therapies for the treatment of cancer.
Where is BioAtla based and how big is it?
BioAtla is based in San Diego, California, United States. Fundz records about 51 employees.
Who are the decision-makers at BioAtla?
Fundz holds 1 contact at BioAtla, including the CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as BioAtla that raised within 45 days of this round, from Fundz verified event records.

  • VistaGen raised $1.9M on August 6, 2015.
  • Protagonist Therapeutics, Inc raised $17M on July 24, 2015.
  • CUREMARK LLC raised $20M on July 13, 2015.
  • Kezar Life Sciences raised $28M on June 22, 2015.
  • Monopar Therapeutics raised $2.1M (Seed) on June 18, 2015.
  • Milestone Pharmaceuticals raised $3.8M (Seed) on June 16, 2015.

Who to call at BioAtla, and when

A new round usually means BioAtla is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BioAtla raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioAtla, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioAtla. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioAtla

Location

San Diego, California, United States

About

BioAtla, Inc. is a biotechnology company focused on the development of innovative therapies for the treatment of cancer. The company leverages its proprietary technology platform to create unique antibody-drug conjugates. BioAtla aims to provide improved therapeutic solutions for patients suffering from cancer. Headquartered in San Diego, California, it is committed to advancing oncology treatments.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioAtla raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsLauri K., CEOSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for BioAtla's next move

See what Strategic adds

BioAtla raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.